Impact of vascular liver disease on the menstrual cycle and metabolic status in premenopausal women - 12/01/22
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
| pagine | 10 |
| Iconografia | 2 |
| Video | 0 |
| Altro | 0 |
Highlights |
• | Vascular liver diseases are associated with menstrual cycle and endocrine abnormalities. |
• | Clinical and/or biological features of hyperandrogenism are frequent in these women. |
• | Increase in SHBG and decrease in IGF1 could be viewed as the hallmark of hepatic failure. |
• | Progestin contraception is well tolerated in these women. |
Abstract |
Background |
Vascular liver disease (VLD) are rare liver diseases, which affect women at reproductive ages. Main complications are bleeding (portal hypertension, thrombopenia or anticoagulation related) and thromboembolism. Failure of liver function can occur. Thus endocrine abnormalities management and contraception are challenging.
Purpose |
to evaluate the impact on the menstrual cycles and related endocrine abnormalities in women with VLD and respective roles of liver function and portal hypertension.
Study design |
This was a single-center observational cohort study. Forty-seven premenopausal women with vascular liver disease were included for endocrine and gynecological assessments. Endocrine evaluation was performed at inclusion. Tolerance of contraception was followed up and assessed at 3 and 12 months.
Participants, Setting, Methods |
Forty-seven women (aged 16–50) followed in a Reference Center for Liver Vascular Disease between February 2009 and November 2016 were included and addressed for gynecological and endocrinological management. Twenty-five women had extrahepatic portal vein obstruction, 17 had Budd Chiari Syndrome and five had a porto-sinusoidal vascular disease. We explored gonadotropin at baseline and after GnRH, testosterone, sex hormone binding globulin (SHBG), androstenedione, GH axis and glucose metabolism. All women underwent pelvic ultrasonography.
Results |
Vascular liver disease was associated with abnormal menstrual cycles in 53% of the women and clinical and/or biological hyperandrogenism and/or a polycystic ovary morphology was identified in 38%. Portal hypertension was correlated to higher testosterone levels (P = 0.04), whereas higher elevated levels SHBG in 28%, correlated with liver failure (P = 0.01). Sixteen had glucose intolerance profile or diabetes. IGF-1 levels were highly correlated with hepatic failure. Abnormal uterine bleeding occurred in 21% of women, 87% of which were due to gynecological pathologies revealed by anticoagulant treatment. Progestin contraception was well tolerated and helped to control bleeding.
Conclusion and implications |
endocrine abnormalities, prior described in association with cirrhosis, are also identified in patients with vascular liver disease, and require specific management. Glucose intolerance profile is frequent, further studies are needed to assess significant consequences on cardio-vascular system.
Il testo completo di questo articolo è disponibile in PDF.Keywords : Budd-Chiari syndrome, Portal vein thrombosis, Portal hypertension, Hyperandrogenism, Contraception, IgF-1
Mappa
Vol 46 - N° 1
Articolo 101756- Gennaio 2022 Ritorno al numero
Articolo precedente
- How will NAFLD change the liver transplant landscape in the 2020s?
- François Villeret, Jérôme Dumortier, Domitille Erard-Poinsot
- Comparison of Interferon-α-based therapy and nucleos(t)ide analogs in preventing adverse outcomes in patients with chronic hepatitis B
- Qian-Guo Mao, Hui-Qing Liang, Ya-Lin Yin, Jin-Mo Tang, Jia-En Yang, Chun-Cheng Wu, Yue Chen, Man-Ying Zhang, Yao-Yu Liu, Xiao-Ting Zheng, Lin-Yi Zhuang, Shao-Dong Chen
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?